Evogene Ltd. ( EVGN) - Key Metrics
EVGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.04 | $0.44 | -$0.43 | -$0.44 |
| 2025Q2 | $0.12 | -$0.62 | -$0.32 | -$0.32 |
| 2025Q1 | $0.36 | -$0.38 | -$0.76 | -$0.78 |
EVGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | 0.67 |
| 2025Q2 | ? | -0.53 |
| 2025Q1 | ? | -0.84 |
EVGN
Price: $0.63
52 week price:
Earnings Per Share: -1.70 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 71621
Ebitda: -8.5 millionMarket Capitalization: 7.3 million